The Effect of Acupressure on Multiple Sclerosis Patients
MS
The Effect of Acupressure on Pain, Fatigue, Sleep, and Quality of Life in Multiple Sclerosis Patients
2 other identifiers
interventional
90
1 country
1
Brief Summary
There are studies in the literature evaluating the effects of acupressure application in MS patients. In a study; it was shown that acupressure application reduced pain and fatigue. In a study; acupressure was found to reduce fatigue and depression scores. In a study; acupressure was found to improve the patient's physical and cognitive functions and quality of life. In a study; acupressure was found to have positive effects on reducing fatigue in MS patients. In a study acupressure application was found to have significant effects in reducing fatigue. There are no studies evaluating the combined effects of acupressure on fatigue, pain, sleep quality, and quality of life parameters in MS patients. This study is planned to determine the effects of acupressure on fatigue, pain, sleep quality, and quality of life in MS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 7, 2026
CompletedFirst Posted
Study publicly available on registry
April 30, 2026
CompletedApril 30, 2026
April 1, 2026
8 months
April 7, 2026
April 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Fatigue Severity Scale (FSS)
The FSS is a 9-item scale used to assess the impact of fatigue on daily activities. Each item is rated on a 7-point Likert scale ranging from 1 to 7. The total score is the average of the 9 items. Scores range from 1 to 7, where higher scores indicate greater fatigue severity (worse outcome).
Baseline, at the end of the 3rd week, and at the end of the 6th week.
Secondary Outcomes (3)
Visual Analog Scale (VAS) for Pain
Baseline, at the end of the 3rd week, and at the end of the 6th week.
Pittsburgh Sleep Quality Index (PSQI)
Baseline, at the end of the 3rd week, and at the end of the 6th week.
Multiple Sclerosis Quality of Life-54 (MSQOL-54)
Baseline, at the end of the 3rd week, and at the end of the 6th week.
Study Arms (3)
intervention
EXPERIMENTALintervention
sham
SHAM COMPARATORPlasebo
Control
NO INTERVENTIONControl
Interventions
Eligibility Criteria
You may qualify if:
- At least 6 months of confirmed MS diagnosis
- With RRMS
- Aged 18 years or older
- With a pain score of VAS≥3
- Not having used pain medication in the last 8 hours prior to the acupressure session
- With a Fatigue Severity Scale score of 4 or higher
- Without a diagnosis of cancer
- Without diabetes
- No neurological disease other than MS
- Not receiving any other complementary treatment
- Non-smoker
- Literate and able to communicate
- No deformity or lesion in the areas where acupressure will be applied
- No mental problems that could prevent cooperation with the acupressure application
- Not taking sedative medication
- +5 more criteria
You may not qualify if:
- Patients who did not attend at least 4 sessions
- Patients who wish to withdraw from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of Harran University
Sanliurfa, Şanlıurfa, 63000, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 7, 2026
First Posted
April 30, 2026
Study Start
March 1, 2025
Primary Completion
November 1, 2025
Study Completion
April 1, 2026
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share